14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 MGNX stock ended at $16.05. This is 1.95% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 4.80% from a day low at $15.62 to a day high of $16.37.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical MacroGenics prices

Date Open High Low Close Volume
May 07, 2024 $16.32 $16.37 $15.62 $16.05 722 604
May 06, 2024 $15.68 $16.44 $15.36 $16.37 623 050
May 03, 2024 $15.64 $16.14 $15.32 $15.67 604 700
May 02, 2024 $15.68 $15.99 $15.16 $15.22 555 450
May 01, 2024 $14.77 $16.30 $14.77 $15.55 938 308
Apr 30, 2024 $14.65 $14.96 $14.19 $14.78 695 481
Apr 29, 2024 $14.54 $15.05 $14.49 $14.82 499 144
Apr 26, 2024 $15.22 $15.26 $14.22 $14.56 649 082
Apr 25, 2024 $14.93 $15.59 $14.13 $14.37 1 198 580
Apr 24, 2024 $16.16 $16.48 $15.47 $15.70 521 665
Apr 23, 2024 $15.65 $16.59 $15.63 $16.23 646 310
Apr 22, 2024 $15.73 $15.77 $14.94 $15.41 754 981
Apr 19, 2024 $15.96 $16.33 $15.24 $15.61 1 019 334
Apr 18, 2024 $15.99 $16.38 $15.82 $16.07 567 634
Apr 17, 2024 $16.74 $16.83 $16.00 $16.10 922 188
Apr 16, 2024 $17.48 $17.48 $16.62 $16.68 615 389
Apr 15, 2024 $17.48 $17.72 $16.67 $16.94 806 988
Apr 12, 2024 $18.38 $18.54 $17.12 $17.54 860 025
Apr 11, 2024 $18.43 $19.08 $17.96 $18.51 1 133 519
Apr 10, 2024 $17.73 $18.41 $17.45 $18.25 1 239 683
Apr 09, 2024 $19.50 $19.54 $17.94 $18.10 1 582 167
Apr 08, 2024 $18.42 $18.71 $18.01 $18.35 2 026 418
Apr 05, 2024 $17.66 $19.03 $17.45 $18.24 2 492 483
Apr 04, 2024 $15.07 $18.90 $15.07 $17.78 6 803 992
Apr 03, 2024 $13.19 $13.71 $12.82 $13.67 1 288 031
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT